• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗补助参保人群中阿片类物质使用障碍患者的诊所转换模式及药物治疗连续性

Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.

作者信息

Cole Evan S, Drake Coleman, DiDomenico Ellen, Sharbaugh Michael, Kim Joo Yeon, Nagy Dylan, Cochran Gerald, Gordon Adam J, Gellad Walid F, Pringle Janice, Warwick Jack, Chang Chung-Chou H, Kmiec Julie, Kelley David, Donohue Julie M

机构信息

University of Pittsburgh Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Pittsburgh, PA, 15261, United States.

University of Pittsburgh Graduate School of Public Health, Department of Health Policy and Management, 130 DeSoto Street, Pittsburgh, PA, 15261, United States.

出版信息

Drug Alcohol Depend. 2021 Apr 1;221:108633. doi: 10.1016/j.drugalcdep.2021.108633. Epub 2021 Feb 16.

DOI:10.1016/j.drugalcdep.2021.108633
PMID:33631544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8931627/
Abstract

BACKGROUND

Many persons with opioid use disorder (OUD) initiate medication for opioid use disorder (MOUD) with one clinic and switch to another clinic during their course of treatment. These switches may occur for referrals or for unplanned reasons. It is unknown, however, what effect switching MOUD clinics has on continuity of MOUD treatment or on overdoses.

OBJECTIVE

To examine patterns of switching MOUD clinics and its association with the proportion of days covered (PDC) by MOUD, and opioid-related overdose.

DESIGN

Cross-sectional retrospective analysis of Pennsylvania Medicaid claims data.

MAIN MEASURES

MOUD clinic switches (i.e., filling a MOUD prescription from a prescriber located in a different clinic than the previous prescriber), PDC, and opioid-related overdose.

RESULTS

Among 14,107 enrollees, 43.2 % switched clinics for MOUD at least once during the 270 day period. In multivariate regression results, enrollees who were Non-Hispanic black (IRR = 1.43; 95 % CI = 1.24-1.65; p < 0.001), had previous methadone use (IRR = 1.32; 95 % CI = 1.13-1.55; p < 0.001), and a higher total number of office visits (IRR = 1.01; CI = 1.01-1.01; p < 0.001) had more switches. The number of clinic switches was positively associated with PDC (OR = 1.12; 95 % CI = 1.10-1.13). In secondary analyses, we found that switches for only one MOUD fill were associated with lower PDC (OR = 0.97; 95 % CI = 0.95-0.99), while switches for more than one MOUD fill were associated with higher PDC (OR = 1.40; 95 % CI = 1.36-1.44). We did not observe a relationship between opioid-related overdose and clinic switches.

CONCLUSIONS

Lack of prescriber continuity for receiving MOUD may not be problematic as it is for other conditions, insofar as it is related to overdose and PDC.

摘要

背景

许多患有阿片类药物使用障碍(OUD)的人在一家诊所开始接受阿片类药物使用障碍药物治疗(MOUD),并在治疗过程中转到另一家诊所。这些转诊可能是出于转诊目的或出于意外原因。然而,尚不清楚转至其他MOUD诊所对MOUD治疗的连续性或过量用药有何影响。

目的

研究MOUD诊所转诊模式及其与MOUD覆盖天数比例(PDC)和阿片类药物相关过量用药的关联。

设计

对宾夕法尼亚州医疗补助索赔数据进行横断面回顾性分析。

主要指标

MOUD诊所转诊(即从与前一位开处方者所在诊所不同的开处方者处开具MOUD处方)、PDC和阿片类药物相关过量用药。

结果

在14107名登记者中,43.2%的人在270天内至少有一次转至其他诊所接受MOUD治疗。在多变量回归结果中,非西班牙裔黑人登记者(发病率比值比[IRR]=1.43;95%置信区间[CI]=1.24-1.65;p<0.001)、曾使用过美沙酮的登记者(IRR=1.32;95%CI=1.13-1.55;p<0.001)以及门诊就诊总次数较多的登记者(IRR=1.01;CI=1.01-1.01;p<0.001)转诊次数更多。诊所转诊次数与PDC呈正相关(比值比[OR]=1.12;95%CI=1.10-1.13)。在二次分析中,我们发现仅因一次MOUD配药而转诊与较低的PDC相关(OR=0.97;95%CI=0.95-0.99),而因多次MOUD配药而转诊与较高的PDC相关(OR=1.40;95%CI=1.36-1.44)。我们未观察到阿片类药物相关过量用药与诊所转诊之间的关系。

结论

就过量用药和PDC而言,接受MOUD时缺乏开处方者的连续性可能不像其他情况那样存在问题。

相似文献

1
Patterns of clinic switching and continuity of medication for opioid use disorder in a Medicaid-enrolled population.医疗补助参保人群中阿片类物质使用障碍患者的诊所转换模式及药物治疗连续性
Drug Alcohol Depend. 2021 Apr 1;221:108633. doi: 10.1016/j.drugalcdep.2021.108633. Epub 2021 Feb 16.
2
Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.11 个州医疗补助受助人中阿片类药物使用障碍药物治疗持续时间与过量用药风险的关系:一项回顾性队列研究。
Addiction. 2022 Dec;117(12):3079-3088. doi: 10.1111/add.15959. Epub 2022 Jun 13.
3
Opioid Overdose After Medication for Opioid Use Disorder Initiation Following Hospitalization or ED Visit.住院或急诊就诊后开始治疗阿片类药物使用障碍时的阿片类药物过量。
JAMA Netw Open. 2024 Jul 1;7(7):e2423954. doi: 10.1001/jamanetworkopen.2024.23954.
4
Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.阿片类药物过量幸存者:美沙酮患者药物滥用障碍和重复过量用药的风险。
Drug Alcohol Depend. 2022 Mar 1;232:109269. doi: 10.1016/j.drugalcdep.2022.109269. Epub 2022 Jan 10.
5
Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.佛罗里达州医疗补助人群中阿片类药物使用障碍的治疗:使用连续护理模型评估质量。
Am J Drug Alcohol Abuse. 2021 Mar 4;47(2):220-228. doi: 10.1080/00952990.2020.1824236. Epub 2020 Oct 15.
6
Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.俄勒冈州医疗补助计划中患有阿片类药物使用障碍患者的治疗环境与结局之间的关联:一项回顾性队列研究。
Addict Sci Clin Pract. 2022 Aug 19;17(1):45. doi: 10.1186/s13722-022-00318-1.
7
The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.在全州范围内的惩教系统中实施阿片类药物使用障碍治疗药物和 COVID-19 对治疗参与度、释放后继续治疗和药物过量的影响。
J Subst Use Addict Treat. 2023 Sep;152:209103. doi: 10.1016/j.josat.2023.209103. Epub 2023 Jun 11.
8
Racial and Ethnic Inequities in Buprenorphine and Methadone Utilization Among Reproductive-Age Women with Opioid Use Disorder: an Analysis of Multi-state Medicaid Claims in the USA.美国多州医疗补助索赔中的阿片类药物使用障碍生殖年龄妇女布比卡因和美沙酮利用中的种族和民族不平等现象分析。
J Gen Intern Med. 2023 Dec;38(16):3499-3508. doi: 10.1007/s11606-023-08306-0. Epub 2023 Jul 12.
9
Using machine learning to study the effect of medication adherence in Opioid Use Disorder.利用机器学习研究阿片类药物使用障碍中药物依从性的影响。
PLoS One. 2022 Dec 15;17(12):e0278988. doi: 10.1371/journal.pone.0278988. eCollection 2022.
10
Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.美国长期接受阿片类药物治疗的人群和阿片类药物使用障碍人群的尿液药物监测趋势。
Pain Physician. 2021 Mar;24(2):E249-E256.

引用本文的文献

1
Composition of buprenorphine prescribing networks in Medicaid and association with quality of care.医疗补助计划中丁丙诺啡处方网络的构成及其与医疗质量的关联。
J Subst Use Addict Treat. 2024 Aug;163:209363. doi: 10.1016/j.josat.2024.209363. Epub 2024 Apr 18.

本文引用的文献

1
Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.初级保健提供者和专科医生提供可比的丁丙诺啡治疗质量。
Health Aff (Millwood). 2020 Aug;39(8):1395-1404. doi: 10.1377/hlthaff.2019.01559.
2
Early Discontinuation of Buprenorphine Therapy for Opioid Use Disorder Among Privately Insured Adults.阿片类物质使用障碍患者中私人保险成年人丁丙诺啡治疗的早期停药。
Psychiatr Serv. 2020 Aug 1;71(8):779-788. doi: 10.1176/appi.ps.201900309. Epub 2020 Apr 8.
3
Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.与用于阿片类物质使用障碍的短效药物相比,对长效注射剂和植入式药物的认知及偏好。
J Subst Abuse Treat. 2020 Apr;111:54-66. doi: 10.1016/j.jsat.2020.01.009. Epub 2020 Jan 21.
4
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia.澳大利亚经常使用阿片类药物的人群对用于治疗阿片类药物使用障碍的丁丙诺啡延长释放注射剂的看法。
Addiction. 2020 Jul;115(7):1295-1305. doi: 10.1111/add.14941. Epub 2020 Feb 5.
5
Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.对阿片类药物使用障碍药物的态度:一项针对解决了物质使用问题的美国个人的全国性研究结果。
Exp Clin Psychopharmacol. 2020 Aug;28(4):449-461. doi: 10.1037/pha0000325. Epub 2019 Sep 26.
6
A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective.从支付方角度来看,美沙酮和丁丙诺啡治疗阿片类使用障碍 Medicaid 患者的依从性、结局和成本比较。
J Subst Abuse Treat. 2019 Sep;104:15-21. doi: 10.1016/j.jsat.2019.05.015. Epub 2019 May 31.
7
Care continuity impacts medicare expenditures of older adults: Fact or fiction?老年人的医疗连续性是否影响医疗保险支出:事实还是虚构?
Healthc (Amst). 2020 Mar;8(1):100364. doi: 10.1016/j.hjdsi.2019.05.004. Epub 2019 May 30.
8
Buprenorphine Treatment for Opioid Use Disorder: An Overview.阿片类物质使用障碍的丁丙诺啡治疗:概述。
CNS Drugs. 2019 Jun;33(6):567-580. doi: 10.1007/s40263-019-00637-z.
9
Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence.提供者和患者对丁丙诺啡依从性障碍的看法,以及视频直接观察治疗以提高依从性的可接受性。
Addict Sci Clin Pract. 2019 Mar 13;14(1):11. doi: 10.1186/s13722-019-0139-3.
10
Evaluation of a Medicaid Lock-in Program: Increased Use of Opioid Use Disorder Treatment but No Impact on Opioid Overdose Risk.评估医疗补助锁定计划:阿片类药物使用障碍治疗的使用增加,但对阿片类药物过量风险没有影响。
Med Care. 2019 Mar;57(3):213-217. doi: 10.1097/MLR.0000000000001058.